General anesthetic may lead to new epilepsy treatments
August 05, 2024
August 05, 2024
ITHACA, New York, Aug. 5 -- Cornell University issued the following news:
The general anesthetic propofol may hold the keys to developing new treatment strategies for epilepsy and other neurological disorders, according to a study led by researchers at Weill Cornell Medicine and Sweden's Linkoping University.
In their study, published July 31 in Nature, the researchers determined the high-resolution structural details of how propofol inhibits the activity of HCN1, . . .
The general anesthetic propofol may hold the keys to developing new treatment strategies for epilepsy and other neurological disorders, according to a study led by researchers at Weill Cornell Medicine and Sweden's Linkoping University.
In their study, published July 31 in Nature, the researchers determined the high-resolution structural details of how propofol inhibits the activity of HCN1, . . .